Literature DB >> 6208036

Suppression of IgE responses in inbred rats by repeated respiratory tract exposure to antigen: responder phenotype influences isotype specificity of induced tolerance.

J D Sedgwick, P G Holt.   

Abstract

Repeated exposure of rats to an aerosol of ovalbumin (OVA) induced tolerance to subsequent parenteral challenge with the same antigen. In the low-IgE responder WAG strain, responses in both the IgE and IgG classes were affected, whereas rats of the moderate (Lou/M) and high-IgE responder BN strain developed high titers of anti-OVA IgG in serum during exposure with concomitant tolerance in the IgE class. Repeated parenteral challenge, however, failed to elicit significant secondary anti-OVA IgG responses in the Lou/M and BN strains, suggesting that the isotype specificity of induced tolerance in these strains was not absolute. Spleen and respiratory tract lymph node cells, but not serum from aerosol-exposed BN rats, were capable of transferring IgE isotype- and antigen-specific tolerance. Dose response experiments demonstrated that the low-IgE responder WAG strain was exquisitely sensitive to tolerance induction in response to antigen inhalation, being susceptible to dosages in the nanogram range; at least 1000 times more antigen was required in the high-IgE responder BN to induce comparable tolerance in the IgE class. It was also apparent that the IgE isotype was more readily suppressed than the IgG isotype in both high- and low-IgE responder strains.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208036     DOI: 10.1002/eji.1830141006

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

Authors:  M Vukmanovic-Stejic; M J Thomas; A Noble; D M Kemeny
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

2.  Asthma and indoor environment in Nepal.

Authors:  T Melsom; L Brinch; J O Hessen; M A Schei; N Kolstrup; B K Jacobsen; C Svanes; M R Pandey
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

3.  Phenotypic changes to the endogenous antigen-specific CD8+ T cell response correlates with the development and resolution of allergic airway disease.

Authors:  Jeffrey T McNamara; Craig M Schramm; Anurag Singh; Eric R Secor; Linda A Guernsey; Leo Lefrançois; Roger S Thrall
Journal:  Am J Pathol       Date:  2012-03-24       Impact factor: 4.307

4.  Long-term maintenance of localized antibody responses in the lung.

Authors:  D E Bice; D N Weissman; B A Muggenburg
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

5.  Suppression of IgE responses by antigen inhalation: failure of tolerance mechanism(s) in newborn rats.

Authors:  P G Holt; J Vines; D Britten
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

6.  Population dynamics of lymphocyte subsets in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis.

Authors:  R Dörries; S Schwender; H Imrich; H Harms
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

7.  The pathogenic role of virus-specific antibody-secreting cells in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis.

Authors:  S Schwender; H Imrich; R Dörries
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

8.  Down-regulation of immune responses to inhaled antigen: studies on the mechanism of induced suppression.

Authors:  J D Sedgwick; P G Holt
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

9.  Splenic regulation of the murine pulmonary lymph node response.

Authors:  E M Allen; P Abramoff; J N Fink; N J Calvanico
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

10.  Suppression of IgE responses by antigen inhalation: studies on the role of genetic and environmental factors.

Authors:  P G Holt; D Britten; J D Sedgwick
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.